RemeGen Co

RemeGen Co Deferred Tax Liabilities

The Deferred Tax Liabilities of RemeGen Co (688331.SS) as of Nov 3, 2026 is 1.51 M CNY. In the previous year, Deferred Tax Liabilities was 40,300.00 CNY — a change of 3,649.88% (higher).

Deferred Tax Liabilities

1.51 MCNY

YoY

3,649.88%

Last updated:

Deferred Tax Liabilities of RemeGen Co is 2023 1.51 M CNY. Deferred Tax Liabilities of RemeGen Co was 2022 40,300.00 CNY. It decreases by 3,649.88% higher compared to the previous year.

The RemeGen Co Deferred Tax Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Deferred Tax Liabilities
Date
Deferred Tax Liabilities
Jan 1, 2020
700,000.00 CNY
Jan 1, 2021
300,000.00 CNY
Jan 1, 2022
40,300.00 CNY
Jan 1, 2023
1.51 M CNY
The RemeGen Co Deferred Tax Liabilities history
YEARDeferred Tax LiabilitiesYoY
1.51 MCNY+3,649.88%
40,300.00CNY-86.57%
300,000.00CNY-57.14%
700,000.00CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

RemeGen Co Stock analysis

What does RemeGen Co do? RemeGen Co Ltd generates revenue by researching, developing, and manufacturing innovative biopharmaceuticals, specifically focusing on therapeutic antibody drugs. The company's product portfolio includes tetacept (RC18), veldicitumab (RC48), and a dual-target fusion protein (RC28). These products are designed to treat major diseases such as oncology, autoimmune diseases, and ophthalmology. The firm operates primarily in the domestic market within China, where it commercializes its discoveries. Its business model relies on the development of various antibody types, including antibody drug conjugates (ADCs), antibody fusion proteins, monoclonal antibodies, and bispecific antibodies. This focus allows the company to address significant medical needs through its specialized therapeutic offerings. RemeGen Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RemeGen Co stock

Deferred Tax Liabilities of RemeGen Co is 1.51 M CNY in 2023.

Deferred Tax Liabilities of RemeGen Co changed from 40,300.00 CNY to 1.51 M CNY, representing a 3,649.88% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Deferred Tax Liabilities RemeGen Co since 2006 – with annual values, charts, and detailed analysis.

Deferred tax liabilities arise from temporary differences between accounting and tax treatments. They represent taxes owed in the future on income already recognized.

Deferred Tax Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Deferred Tax Liabilities's RemeGen Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — RemeGen Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — RemeGen Co